Frank B. Cortazar

3.6k total citations · 1 hit paper
40 papers, 1.3k citations indexed

About

Frank B. Cortazar is a scholar working on Pulmonary and Respiratory Medicine, Nephrology and Genetics. According to data from OpenAlex, Frank B. Cortazar has authored 40 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 14 papers in Nephrology and 12 papers in Genetics. Recurrent topics in Frank B. Cortazar's work include Vasculitis and related conditions (16 papers), Renal Diseases and Glomerulopathies (14 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (10 papers). Frank B. Cortazar is often cited by papers focused on Vasculitis and related conditions (16 papers), Renal Diseases and Glomerulopathies (14 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (10 papers). Frank B. Cortazar collaborates with scholars based in United States, United Kingdom and Canada. Frank B. Cortazar's co-authors include John L. Niles, David E. Leaf, Karen Laliberte, William F. Pendergraft, John H. Stone, Ilya Glezerman, M Yamashita, Kenneth M. Ralto, Dung T. Le and Lynn D. Cornell and has published in prestigious journals such as New England Journal of Medicine, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Frank B. Cortazar

34 papers receiving 1.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors

2016 452 citations Frank B. Cortazar, Kristen A. Marrone et al. Kidney International profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frank B. Cortazar United States	16	602	594	357	222	196	40	1.3k
Haiyan Wang China	14	320 0.5×	227 0.4×	359 1.0×	91 0.4×	140 0.7×	54	939
Jean Tayar United States	10	138 0.2×	453 0.8×	76 0.2×	185 0.8×	231 1.2×	30	846
G.S.C. Chiang Singapore	17	166 0.3×	147 0.2×	490 1.4×	80 0.4×	136 0.7×	41	997
Yasemin Özlük Türkiye	18	280 0.5×	147 0.2×	247 0.7×	37 0.2×	95 0.5×	118	1.0k
Wan-zhong Zou China	17	417 0.7×	75 0.1×	737 2.1×	124 0.6×	421 2.1×	49	1.2k
Philippe Rouvier France	15	169 0.3×	231 0.4×	142 0.4×	55 0.2×	65 0.3×	45	964
Joichi Usui Japan	18	407 0.7×	49 0.1×	431 1.2×	104 0.5×	183 0.9×	90	1.0k
Sophie Dimonaco United Kingdom	11	861 1.4×	86 0.1×	115 0.3×	396 1.8×	921 4.7×	18	1.5k
Haruhiko Ninomiya Japan	21	131 0.2×	108 0.2×	273 0.8×	321 1.4×	133 0.7×	82	1.3k
Erasmia Psimenou Greece	22	81 0.1×	408 0.7×	282 0.8×	261 1.2×	159 0.8×	69	1.5k

Countries citing papers authored by Frank B. Cortazar

Since Specialization

Citations

This map shows the geographic impact of Frank B. Cortazar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank B. Cortazar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank B. Cortazar more than expected).

Fields of papers citing papers by Frank B. Cortazar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank B. Cortazar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank B. Cortazar. The network helps show where Frank B. Cortazar may publish in the future.

Co-authorship network of co-authors of Frank B. Cortazar

This figure shows the co-authorship network connecting the top 25 collaborators of Frank B. Cortazar. A scholar is included among the top collaborators of Frank B. Cortazar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank B. Cortazar. Frank B. Cortazar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yalavarthy, Rajesh, Ju-Young Moon, Inwhee Park, et al.. (2025). Povetacicept for IgA Nephropathy and Primary Membranous Nephropathy. Kidney International Reports. 11(1). 106–116.

Efe, Orhan, Anushya Jeyabalan, Ayman Al Jurdi, et al.. (2025). Persistent B Cell Depletion After Rituximab for Autoimmune and Glomerular Diseases: A Case Series. Kidney International Reports. 10(5). 1441–1449.

Cortazar, Frank B., et al.. (2025). The Case | A rare cause of acute kidney injury and proteinuria. Kidney International. 107(2). 365–366.

Tumlin, James A., Sreedhar Mandayam, Frank B. Cortazar, et al.. (2024). WCN24-762 UPDATED RESULTS FROM THE RUBY-3 STUDY OF POVETACICEPT, AN ENHANCED DUAL BAFF/APRIL ANTAGONIST, IN AUTOANTIBODY-ASSOCIATED GLOMERULONEPHRITIS. Kidney International Reports. 9(4). S505–S505. 1 indexed citations

Cortazar, Frank B., et al.. (2024). A Phase 1b, Single-Arm, Open-Label Study of Budoprutug, an Anti-CD19 Monoclonal Antibody with Enhanced Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), in Primary Membranous Nephropathy. Journal of the American Society of Nephrology. 35(10S). 1 indexed citations

Zonozi, Reza, Frank B. Cortazar, Anushya Jeyabalan, et al.. (2023). Maintenance of remission of ANCA vasculitis by rituximab based on B cell repopulation versus serological flare: a randomised trial. Annals of the Rheumatic Diseases. 83(3). 351–359. 14 indexed citations

Cortazar, Frank B., David Jayne, Annette Bruchfeld, & Pirow Bekker. (2022). Renal Recovery for Patients With Baseline eGFR ≤20 in Avacopan ADVOCATE Trial. Journal of the American Society of Nephrology. 33(11S). 501–501. 1 indexed citations

Zonozi, Reza, Karen Laliberte, Anushya Jeyabalan, et al.. (2021). Combination of Rituximab, Low-Dose Cyclophosphamide, and Prednisone for Primary Membranous Nephropathy: A Case Series With Extended Follow Up. American Journal of Kidney Diseases. 78(6). 793–803. 38 indexed citations

Zonozi, Reza, Zachary S. Wallace, Karen Laliberte, et al.. (2020). Incidence, Clinical Features, and Outcomes of Late‐Onset Neutropenia From Rituximab for Autoimmune Disease. Arthritis & Rheumatology. 73(2). 347–354. 25 indexed citations

10.

Cortazar, Frank B. & Reza Zonozi. (2020). Drug-Induced Glomerulonephritis. 19(2). 156–164.

11.

Seethapathy, Harish, Sophia Zhao, Donald F. Chute, et al.. (2019). The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors. Clinical Journal of the American Society of Nephrology. 14(12). 1692–1700. 205 indexed citations

12.

Wallace, Zachary S., Rachel Wallwork, Yuqing Zhang, et al.. (2018). Improved survival with renal transplantation for end-stage renal disease due to granulomatosis with polyangiitis: data from the United States Renal Data System. Annals of the Rheumatic Diseases. 77(9). 1333–1338. 20 indexed citations

13.

Miloslavsky, Eli M., John L. Niles, Zachary S. Wallace, et al.. (2018). Reducing glucocorticoid duration in ANCA-associated vasculitis: A pilot trial. Seminars in Arthritis and Rheumatism. 48(2). 288–292. 15 indexed citations

14.

Cortazar, Frank B., et al.. (2017). Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series. BMC Nephrology. 18(1). 44–44. 20 indexed citations

15.

Palamara, Kerri, et al.. (2017). Case 32-2017. New England Journal of Medicine. 377(16). 1569–1578. 1 indexed citations

16.

Cortazar, Frank B., Saif A. Muhsin, William F. Pendergraft, et al.. (2017). Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis. Kidney International Reports. 3(2). 394–402. 72 indexed citations

17.

Cortazar, Frank B., Kristen A. Marrone, Megan L. Troxell, et al.. (2016). Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors. Kidney International. 90(3). 638–647. 452 indexed citations breakdown →

18.

Isakova, Tamara, Hua-Tao Xie, Shari Messinger, et al.. (2012). Inhibitors of mTOR and Risks of Allograft Failure and Mortality in Kidney Transplantation. American Journal of Transplantation. 13(1). 100–110. 42 indexed citations

19.

Cortazar, Frank B., et al.. (2011). Racial and Sex Differences in Prevalence of Hypothyroidism in Patients With Cardiomyopathies Enrolled into a Heart Failure Disease Management Program. Congestive Heart Failure. 17(3). 133–139. 3 indexed citations

20.

Cortazar, Frank B., Miklos Z. Molnar, Tamara Isakova, et al.. (2011). Clinical Outcomes in Kidney Transplant Recipients Receiving Long-Term Therapy With Inhibitors of the Mammalian Target of Rapamycin. American Journal of Transplantation. 12(2). 379–387. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact